Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Trial ◽

Growth Factor Receptor ◽

Advanced Squamous Cell Carcinoma ◽

Concurrent Radiotherapy ◽

Phase I study of anti-epidermal growth factor receptor (anti-EGFR) antibody C225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(98)80497-5 ◽

1998 ◽

Vol 42 (1) ◽

pp. 322

Author(s):

M.P. Ezekiel ◽

F. Robert ◽

R.F. Meredith ◽

S.A. Spencer ◽

J. Newsome ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Growth Factor Receptor ◽

Advanced Squamous Cell Carcinoma ◽

Epidermal Growth ◽

Egfr Antibody

A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies

Investigational New Drugs ◽

10.1007/s10637-010-9444-0 ◽

2010 ◽

Vol 29 (5) ◽

pp. 996-1003 ◽

Cited By ~ 15

Author(s):

Benoit You ◽

Anthony Brade ◽

Joao M. Magalhaes ◽

Lillian L. Siu ◽

Amit Oza ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Dose Escalation ◽

Phase I Trial ◽

Growth Factor Receptor ◽

Solid Malignancies ◽

Results of a phase I trial of the humanized anti epidermal growth factor receptor (EGFr) monoclonal antibody emd 72000 in patients with EGFr expressing solid tumors

European Journal of Cancer ◽

10.1016/s0959-8049(02)80814-0 ◽

2002 ◽

Vol 38 ◽

pp. S53

Keyword(s):

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Solid Tumors ◽

Phase I Trial ◽

Growth Factor Receptor ◽

Faculty Opinions recommendation of Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14346.471799 ◽

2006 ◽

Author(s):

Jeffrey Evans

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Growth Factor Receptor ◽

Advanced Solid Tumors ◽

Irreversible Inhibitor ◽

A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-1447 ◽

2017 ◽

Vol 23 (24) ◽

pp. 7467-7473 ◽

Cited By ~ 16

Author(s):

Helena A. Yu ◽

Alexander Spira ◽

Leora Horn ◽

Jared Weiss ◽

Howard West ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Lung Cancers ◽

Prognostic Significance of Epidermal Growth Factor Receptor Phosphorylation and Mutation in Head and Neck Squamous Cell Carcinoma

The Oncologist ◽

10.1634/theoncologist.2009-0058erratum ◽

2009 ◽

Vol 14 (10) ◽

pp. 1050-1050 ◽

Cited By ~ 1

Author(s):

Takanori Hama ◽

Yuki Yuza ◽

Yoshimichi Saito ◽

Jin O‐uchi ◽

Shu Kondo ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Significance ◽

Growth Factor Receptor ◽

Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma

American Journal of Neuroradiology ◽

10.3174/ajnr.a3349 ◽

2013 ◽

Vol 34 (5) ◽

pp. 1062-1066 ◽

Cited By ~ 7

Author(s):

N.L. Hoefling ◽

J.B. McHugh ◽

E. Light ◽

B. Kumar ◽

H. Walline ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Carcinoma ◽

Head And Neck ◽

Ct Perfusion ◽

Growth Factor Receptor ◽

Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams

British Journal of Oral and Maxillofacial Surgery ◽

10.1016/j.bjoms.2011.02.002 ◽

2012 ◽

Vol 50 (2) ◽

pp. 119-121 ◽

Cited By ~ 3

Author(s):

Abdul Ahmed ◽

Luke Cascarini ◽

Ann Sandison ◽

Peter Clarke

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Human Papilloma Virus ◽

Head And Neck ◽

Growth Factor Receptor ◽

Multidisciplinary Teams ◽

Papilloma Virus ◽

Relationship Between Human Papillomavirus (HPV) Status, Epidermal Growth Factor Receptor (EGFR) and Phospho-EGFR (pEGFR) Expression in Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.817 ◽

2008 ◽

Vol 72 (1) ◽

pp. S23

Author(s):

E.J. Filion ◽

C.S. Kong ◽

B. Narasimhan ◽

H. Cao ◽

J.P. Erickson ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Carcinoma ◽

Head And Neck ◽

Growth Factor Receptor ◽

Hpv Status ◽

137P Epidermal growth factor receptor mutation status and response to tyrosine kinase inhibitors in advanced Chinese female lung squamous cell carcinoma: A retrospective study

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01979-1 ◽

2021 ◽

Vol 16 (4) ◽

pp. S771

Author(s):

Q. Chang ◽

H. Qiang ◽

C. Tianqing

Keyword(s):

Squamous Cell Carcinoma ◽

Retrospective Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Lung Squamous Cell Carcinoma ◽

Mutation Status ◽